Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACTT1 trial of intratympanic esketamine for acute inner ear tinnitus
2011-005384-24Phase 2Completed
- Sponsor
- Altamira Therapeutics
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of esketamine in tinnitus, acute acoustic trauma (AAT), acute otitis media (AOM) and 1 more, sponsored by Altamira Therapeutics. Primary endpoint: Primary assessment of efficacy. Started Nov 2011; status: completed.
02
Drugs
esketamine
03
Conditions
tinnitusacute acoustic trauma (AAT)acute otitis media (AOM)inner ear barotrauma (IEBT)
Beyond the preview
Go deeper on 2011-005384-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005384-24.